SG/PUT/FRESENIUS/30/0.1/19.12.25 Share Price

Warrant

DE000SW94NF6

Market Closed - Bid/Ask 08:58:41 01/07/2024 BST After market 19:14:45
0.44 EUR -2.22% Intraday chart for SG/PUT/FRESENIUS/30/0.1/19.12.25 0.435 -1.14%
Current month+9.76%
1 month+12.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 0.44 -2.22%
28/06/24 0.45 +2.27%
27/06/24 0.44 +2.33%
26/06/24 0.43 -2.27%
25/06/24 0.44 -2.22%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 08:58 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SW94NF
ISINDE000SW94NF6
Date issued 09/05/2024
Strike 30
Maturity 19/12/2025 (536 Days)
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.5
Lowest since issue 0.36
Delta-0.44x
Omega 2.856
Premium9.36x
Gearing6.51x
Moneyness 1.060
Difference Strike 1.7
Difference Strike %+5.67%
Spread 0.01
Spread %2.27%
Theoretical value 0.4350
Implied Volatility 30.56 %
Total Loss Probability 41.42 %
Intrinsic value 0.1700
Present value 0.2650
Break even 25.65 €
Theta-0x
Vega0.01x
Rho-0.02x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.88 EUR
Average target price
37.26 EUR
Spread / Average Target
+33.63%
Consensus